Published in J Gen Microbiol on March 01, 1993
Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev (1996) 10.34
Controlling gene expression in mycobacteria with anhydrotetracycline and Tet repressor. Nucleic Acids Res (2005) 4.00
Tetracycline-inducible gene regulation in mycobacteria. Nucleic Acids Res (2005) 2.12
The Helicobacter pylori UreI protein is not involved in urease activity but is essential for bacterial survival in vivo. Infect Immun (1998) 2.05
Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob Agents Chemother (2003) 1.46
Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis. Appl Environ Microbiol (2005) 1.45
Conditional depletion of KasA, a key enzyme of mycolic acid biosynthesis, leads to mycobacterial cell lysis. J Bacteriol (2005) 1.45
Conditional sigma factor expression, using the inducible acetamidase promoter, reveals that the Mycobacterium tuberculosis sigF gene modulates expression of the 16-kilodalton alpha-crystallin homologue. J Bacteriol (1999) 1.32
M. tuberculosis Ser/Thr protein kinase D phosphorylates an anti-anti-sigma factor homolog. PLoS Pathog (2007) 1.28
A crtB homolog essential for photochromogenicity in Mycobacterium marinum: isolation, characterization, and gene disruption via homologous recombination. J Bacteriol (1997) 1.16
Purification and properties of an amidase from Rhodococcus erythropolis MP50 which enantioselectively hydrolyzes 2-arylpropionamides. J Bacteriol (1996) 1.16
High intracellular level of guanosine tetraphosphate in Mycobacterium smegmatis changes the morphology of the bacterium. Infect Immun (2000) 1.12
Characterization of the twin-arginine translocase secretion system of Mycobacterium smegmatis. J Bacteriol (2006) 1.06
Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. Curr HIV Res (2010) 0.90
Cloning and heterologous expression of an enantioselective amidase from Rhodococcus erythropolis strain MP50. Appl Environ Microbiol (2002) 0.89
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. Antimicrob Agents Chemother (2006) 0.88
Control of CydB and GltA1 expression by the SenX3 RegX3 two component regulatory system of Mycobacterium tuberculosis. PLoS One (2011) 0.88
The two chorismate mutases from both Mycobacterium tuberculosis and Mycobacterium smegmatis: biochemical analysis and limited regulation of promoter activity by aromatic amino acids. J Bacteriol (2007) 0.86
amiA is a negative regulator of acetamidase expression in Mycobacterium smegmatis. BMC Microbiol (2001) 0.85
A novel bicistronic vector for overexpressing Mycobacterium tuberculosis proteins in Escherichia coli. Protein Expr Purif (2008) 0.80
Production of recombinant proteins in Mycobacterium smegmatis for structural and functional studies. Protein Sci (2014) 0.80
L-selective amidase with extremely broad substrate specificity from Ochrobactrum anthropi NCIMB 40321. Appl Environ Microbiol (2005) 0.77
Physical, biochemical, and immunological characterization of a thermostable amidase from Klebsiella pneumoniae NCTR 1. J Bacteriol (1996) 0.77
Biochemical and mutational studies of the Bacillus cereus CECT 5050T formamidase support the existence of a C-E-E-K tetrad in several members of the nitrilase superfamily. Appl Environ Microbiol (2011) 0.77
A standardized production pipeline for high profile targets from Mycobacterium tuberculosis. Proteomics Clin Appl (2016) 0.75
Regulated Expression Systems for Mycobacteria and Their Applications. Microbiol Spectr (2014) 0.75
Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet (1993) 16.75
Childhood experience, interpersonal development, and reproductive strategy: and evolutionary theory of socialization. Child Dev (1991) 5.89
Health and economic policy. BMJ (1995) 5.48
Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun (1972) 5.12
The envelope layers of mycobacteria with reference to their pathogenicity. Adv Microb Physiol (1998) 5.08
Mammalian and bacterial sugar transport proteins are homologous. Nature (1987) 4.46
Vaccination against tuberculosis by DNA injection. Nat Med (1996) 3.76
Attachment of local health authority staff to general practices. 1. A study in three county boroughs with special reference to health visiting. Nurs Times (1968) 3.21
Electron-transparent zone of mycobacteria may be a defence mechanism. Nature (1970) 3.18
General-practitioner hospital beds: a review. Br Med J (1971) 3.14
Therapy of tuberculosis in mice by DNA vaccination. Nature (1999) 2.99
Protein splicing elements: inteins and exteins--a definition of terms and recommended nomenclature. Nucleic Acids Res (1994) 2.97
Genomic analysis reveals variation between Mycobacterium tuberculosis H37Rv and the attenuated M. tuberculosis H37Ra strain. Infect Immun (1999) 2.84
Novel structure of the recA locus of Mycobacterium tuberculosis implies processing of the gene product. J Bacteriol (1991) 2.43
Protein splicing in the maturation of M. tuberculosis recA protein: a mechanism for tolerating a novel class of intervening sequence. Cell (1992) 2.35
Protection against Mycobacterium tuberculosis infection by CD8+ T cells requires the production of gamma interferon. Infect Immun (1998) 2.34
Community-care units and inpatient units as alternatives to the district general hospital. Lancet (1967) 2.32
The nucleotide sequence of the promoter, 16S rRNA and spacer region of the ribosomal RNA operon of Mycobacterium tuberculosis and comparison with Mycobacterium leprae precursor rRNA. J Gen Microbiol (1992) 2.28
Evidence of selection for protein introns in the recAs of pathogenic mycobacteria. EMBO J (1994) 2.04
The walls of Mycobacterium lepraemurium: chemistry and ultrastructure. J Gen Microbiol (1971) 2.02
Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol (1983) 1.95
Mycobacteria and lysosomes: a paradox. Nature (1969) 1.95
1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology (1981) 1.95
Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infect Immun (1997) 1.91
Regulation of the inducible acetamidase gene of Mycobacterium smegmatis. Microbiology (1997) 1.86
An electron-microscope study of rat fibroblasts infected with Mycobacterium lepraemurium. J Pathol (1970) 1.86
A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med (1990) 1.75
Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol (2004) 1.67
The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol (1973) 1.67
Cell walls of Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1976) 1.66
Recognition of a mycobacteria-specific epitope in the 65-kD heat-shock protein by synovial fluid-derived T cell clones. J Exp Med (1990) 1.57
The mycoside capsule of Mycobacterium Avium 357. J Gen Microbiol (1974) 1.56
Tumour necrosis factor-alpha (TNF-alpha) synthesis is associated with the skin and peripheral nerve pathology of leprosy reversal reactions. Clin Exp Immunol (1995) 1.50
Studies on the mycolic acids from the walls of Mycobacterium microti. J Gen Microbiol (1982) 1.49
Protection against tuberculosis by a plasmid DNA vaccine. Vaccine (1997) 1.48
Immunological activity of a 14-kilodalton recombinant protein of Mycobacterium tuberculosis H37Rv. Infect Immun (1987) 1.48
Heterologous expression of the 65-kilodalton antigen of Mycobacterium leprae and murine T-cell responses to the gene product. Infect Immun (1988) 1.48
Micro-processors, macro-economic policy, and public health. Lancet (1979) 1.47
Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiology (1999) 1.42
Identification, sequencing, and expression of Mycobacterium leprae superoxide dismutase, a major antigen. Infect Immun (1990) 1.37
Mycobacterial recA is cotranscribed with a potential regulatory gene called recX. Mol Microbiol (1997) 1.37
Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunology (2001) 1.37
Slow induction of RecA by DNA damage in Mycobacterium tuberculosis. Microbiology (2001) 1.36
Partial nucleotide sequence of 16S ribosomal RNA isolated from armadillo-grown Mycobacterium leprae. J Gen Microbiol (1988) 1.36
Identification of some DNA damage-inducible genes of Mycobacterium tuberculosis: apparent lack of correlation with LexA binding. J Bacteriol (2001) 1.35
Nucleotide sequence and secondary structures of precursor 16S rRNA of slow-growing mycobacteria. Microbiology (1994) 1.35
The "proportional bactericidal test": a method for assessing bactericidal activity in drugs against Mycobacterium leprae in mice. Lepr Rev (1978) 1.33
Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature (1976) 1.32
Expression of a gene for a porin-like protein of the OmpA family from Mycobacterium tuberculosis H37Rv. J Bacteriol (1998) 1.30
Silencing of oxidative stress response in Mycobacterium tuberculosis: expression patterns of ahpC in virulent and avirulent strains and effect of ahpC inactivation. Infect Immun (2001) 1.29
Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology (2000) 1.27
Comparison of 22 species of Mycobacteria by immunodiffusion against an absorbed reference leprosy serum. Int J Lepr Other Mycobact Dis (1981) 1.26
The rRNA operons of Mycobacterium smegmatis and Mycobacterium tuberculosis: comparison of promoter elements and of neighbouring upstream genes. Microbiology (1996) 1.25
Determination of DNA sequences required for regulated Mycobacterium tuberculosis RecA expression in response to DNA-damaging agents suggests that two modes of regulation exist. J Bacteriol (1997) 1.25
Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild-type survival in a mouse infection model. Infect Immun (2001) 1.22
The ribosomal RNA (rrn) operons of fast-growing mycobacteria: primary and secondary structures and their relation to rrn operons of pathogenic slow-growers. Microbiology (1994) 1.21
Crystal structure of the transcription elongation/anti-termination factor NusA from Mycobacterium tuberculosis at 1.7 A resolution. J Mol Biol (2001) 1.20
The ins and outs of protein splicing elements. Mol Microbiol (1994) 1.19
Characterization of Mycobacterium tuberculosis LexA: recognition of a Cheo (Bacillus-type SOS) box. Microbiology (1997) 1.18
Strategies used by pathogenic and nonpathogenic mycobacteria to synthesize rRNA. J Bacteriol (1997) 1.17
Construction and complementation of a recA deletion mutant of Mycobacterium smegmatis reveals that the intein in Mycobacterium tuberculosis recA does not affect RecA function. Mol Microbiol (1998) 1.16
The specific 18-kilodalton antigen of Mycobacterium leprae is present in Mycobacterium habana and functions as a heat-shock protein. J Immunol (1990) 1.16
Serological activity of purified glycolipid from Mycobacterium leprae. Int J Lepr Other Mycobact Dis (1982) 1.12
The aliphatic acylamide amidohydrolase of Mycobacterium smegmatis: its inducible nature and relation to acyl-transfer to hydroxylamine. J Gen Microbiol (1967) 1.11
Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Clin Exp Immunol (1987) 1.11
A new single-copy mycobacterial plasmid, pMF1, from Mycobacterium fortuitum which is compatible with the pAL5000 replicon. Microbiology (2000) 1.10
Effect of purification steps on the immunogenicity of Mycobacterium leprae. Br J Exp Pathol (1980) 1.10
A cooperative taxonomic study of mycobacteria isolated from armadillos infected with Mycobacterium leprae. J Gen Microbiol (1986) 1.09
Quantitative comparison of the mycolic and fatty acid compositions of Mycobacterium leprae and Mycobacterium gordonae. J Gen Microbiol (1985) 1.07
Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India. Int J Lepr Other Mycobact Dis (1993) 1.06
Who is in control? An investigation of nurse and patient beliefs relating to control of their health care. J Adv Nurs (1994) 1.05
Role of Th-1 lymphocytes in the development of protective immunity against Mycobacterium leprae. Analysis of lymphocyte function by polymerase chain reaction detection of cytokine messenger RNA. J Immunol (1992) 1.05
The regulation of macrophage activity in congenitally athymic mice. Eur J Immunol (1984) 1.05
The 16S ribosomal RNA of Mycobacterium leprae contains a unique sequence which can be used for identification by the polymerase chain reaction. J Med Microbiol (1991) 1.05
Effective DNA vaccination of cattle with the mycobacterial antigens MPB83 and MPB70 does not compromise the specificity of the comparative intradermal tuberculin skin test. Vaccine (2000) 1.05
A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol (1996) 1.04
Nucleotide sequences of the spacer-1, spacer-2 and trailer regions of the rrn operons and secondary structures of precursor 23S rRNAs and precursor 5S rRNAs of slow-growing mycobacteria. Microbiology (1994) 1.03
HLA-DR4 restricted lymphocyte proliferation to a Mycobacterium tuberculosis extract in rheumatoid arthritis and healthy subjects. J Immunol (1988) 1.02
The primary-care practitioner -- specialist or jack-of-all trades. N Engl J Med (1975) 1.02
Nucleotide and deduced amino acid sequence of Mycobacterium leprae manganese superoxide dismutase. Nucleic Acids Res (1989) 1.02
Spiritual coping strategies: a review of the nursing research literature. J Adv Nurs (2001) 1.02
Three types of health education. Br Med J (1980) 1.02
Mycobacterium leprae 65hsp antigen expressed from a retroviral vector in a macrophage cell line is presented to T cells in association with MHC class II in addition to MHC class I. Microb Pathog (1992) 1.00
Social science and health policy in the United Kingdom: some contribution of the social sciences to the bureaucratization of the National Health Service. Int J Health Serv (1974) 1.00
Growth and regression of human tumor cell lines in congenitally athymic (rnu/rnu) rats. J Natl Cancer Inst (1981) 1.00
Towards a DNA vaccine against tuberculosis. Vaccine (1994) 0.99
Vaccination of mice against Mycobacterium leprae infection. Infect Immun (1989) 0.99
Drugs for combined therapy: experimental studies on the antileprosy activity of ethionamide and prothionamide, and a general review. Lepr Rev (1978) 0.98
Tumor cells transfected with a bacterial heat-shock gene lose tumorigenicity and induce protection against tumors. J Exp Med (1993) 0.96
Susceptibility of Mycobacterium leprae to the bactericidal activity of mouse peritoneal macrophages and to hydrogen peroxide. J Med Microbiol (1985) 0.96